Physician profile
Amy Brodsky
NPI 1205825056
$21,199.33
in general payments reported to CMS, 2019-2025
21 companies · $1,677 in 2025
The $1,677 reported for 2025 was more than what a typical Procedural Dermatology provider received nationally (typical 2025 total: $599).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2020: $360 · 2021: $1,680 · 2022: $1,863 · 2023: $4,473 · 2024: $11K · 2025: $1,677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Food and Beverage: $1,241 · Travel and Lodging: $379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,435.00 |
| Food and Beverage | $1,241.28 |
| Travel and Lodging | $379.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $16,719.98 | 2019-2025 | |
| Abbvie INC. | $1,924.42 | 2019-2024 | Skyrizi, Rinvoq, Botox |
| Allergan, INC. | $961.81 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $265.52 | 2021-2025 | Dupixent |
| Amgen INC. | $188.93 | 2020-2023 | Otezla |
| Solta Medical, A Division of Bausch Health US, LLC | $181.73 | 2023 | |
| Sun Pharmaceutical Industries INC. | $177.75 | 2019-2022 | |
| Vyne Pharmaceuticals INC. | $118.04 | 2021 | |
| Genzyme Corporation | $111.96 | 2019-2023 | |
| Lilly USA, LLC | $106.89 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $96.90 | 2021-2023 | |
| Surgenex LLC | $87.83 | 2025 | Surgraft, Ardeograft, Pellograft |
| Leo Pharma INC. | $65.92 | 2020-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $42.48 | 2019-2021 | |
| Janssen Biotech, INC. | $39.29 | 2023 | Tremfya |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Epi Health, LLC | $24.32 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $21.05 | 2023 | Sotyktu |
| Journey Medical Corporation | $18.16 | 2022 | |
| Almirall LLC | $17.60 | 2019 | |
| Incyte Corporation | $15.84 | 2023 | Opzelura |
| Strata Skin Sciences, INC. | $12.91 | 2023 | Xtrac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Brodsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.